|
By Eric Jaffe
Special to The Los Angeles Times
November 27, 2006
EVERY week for two years, Michael Hammett stared at
a computer screen, trying to open a flower with his mind. Hammett
had developed a case of carpal tunnel syndrome so severe he needed
surgery. But being a former opiate abuser, he refused to use the
medications that would be needed to control the resulting pain.
Having already tried physical therapy, he set his mind on another
alternative: neurofeedback.
In neurofeedback, people with mental or psychological
conditions learn to regulate and reduce their symptoms — in
Hammett's case, pain — by monitoring their brain waves on
a computer. The treatment is an increasingly popular cousin to biofeedback,
in which people control physical stress by monitoring their heart
rate or muscle tension.
Hammett learned to do both. Electrodes attached to
his scalp transmitted electrical signals from his brain to a computer
displaying a closed white flower. Other sensors were attached to
muscles in both his hands and arms. As Hammett learned what it felt
like to relax these muscles, and therefore reduce his pain, the
flower began to open. Over time, he trained his brain to calm his
central nervous system whenever the pain recurred.
"That image of the flower opening is so burned
into my psyche, in conjunction with the moment of relaxation,"
the 48-year-old Santa Monica resident says, three years after finishing
his therapy.
Neurofeedback has been used for decades in private
clinics, but few well-controlled research studies have been done
— giving it an unscientific reputation. That's beginning to
change.
Researchers are now studying and refining the therapy
— with promising results. Neurofeedback is being used to treat
a growing number of conditions, including chronic pain, attention-deficit
hyperactivity disorder, asthma,
migraines, post-traumatic stress disorder, substance abuse, autism
and a variant of autism called Asperger's syndrome.
"We've done some definitive studies finally that
show it works in important ways," says Eran Zaidel, a professor
of behavioral neuroscience and cognition at UCLA's Brain Research
Institute.
"It's still considered an alternative approach
to medicine, but some people won't do conventional medicine at all,"
he says. "Many, many people are very eager to use this method."
Studies show the advantages
Neurofeedback therapy emerged from work done in the
1960s by psychologist Barry Sterman, now professor emeritus at the
UCLA School of Medicine. He wired electrodes to the heads of cats,
then rewarded them whenever their brain waves reached a frequency
that indicated a relaxed state. In subsequent experiments, Sterman
found, cats that had learned to relax themselves this way had a
higher resistance to the onset of seizures.
The medical applications seemed obvious: If people
learned to relax in such a way, they too might be able to stave
off seizures or anxiety attacks.
Such a method has advantages over simply taking a
pill, says Rob Kall, a neurofeedback practitioner in Newtown, Penn.
"When you're done with medication, it goes out of your system,"
Kall says. But when you're done with
neurofeedback training, the benefits remain.
Perhaps the most researched and accepted application
of neurofeedback is with patients who suffer from ADHD. In 2002,
a clinical team led by psychology professor Vincent J. Monastra,
director of the FPI Attention Disorders
Clinic in Endicott, N.Y., studied 100 children diagnosed with the
condition. All the patients received Ritalin and counseling, but
about half also received neurofeedback. Every week, Monastra hooked
electrodes to the frontal
cortex of these patients and taught them to increase arousal in
that area. Heightened frontal cortex activity reflects a reduction
in hyperactivity and improvements in attention.
After a year, all the patients showed some improvement.
But when the researchers discontinued treatment for a week and reevaluated
the patients, only those who received neurofeedback retained those
improvements.
The neurofeedback appeared to actually change the patients' brain
patterns, the research found, and neurological tests showed greater
activity in the parts of the brain responsible for attention and
behavioral control. The study
was published in the December 2002 issue of the journal Applied
Psychophysiology and Biofeedback.
Between drugs and neurofeedback, only the latter
can potentially offer long-lasting change, says clinical psychologist
Roger deBeus of Eastern Virginia Medical School in Norfolk, Va.
"As the brain becomes more normal, patients don't need as much
or any medication," he says.
Russ Ramsay, associate director of the Adult ADHD
Treatment and Research Program at the University of Pennsylvania,
says patients are intrigued by the possibilities. "More people
are seeking it out and entering into the
treatment," he says. Cravings can be lessened with neurofeedback
too. Clinical psychologist Stephen Sideroff of the UCLA School of
Medicine published the first controlled study examining neurofeedback
as a tool to help substance abusers. The study enrolled 120 patients
from a residential treatment program in Los Angeles; the group included
those who were dependent on alcohol, heroin, crack and methamphetamine.
In addition to counseling, half the patients received
neurofeedback, in which they learned to stabilize certain brain
waves related to stress that comes with the initial phases of substance
abuse recovery. After a year of treatment, 77% of the users who
had received neurofeedback training remained abstinent, compared
with 44% of the control patients, according to research published
in 2005 in the American Journal of Drug and Alcohol Abuse.
Precision up for debate
Some critics of neurofeedback have said it's too imprecise.
Electrodes placed on the scalp can detect brain waves toward the
surface of the brain, they say, but might fail to measure waves
at sub-cortical levels, such as those involved in attention and
arousal regulation. Several advances in neurofeedback, however,
promise more precise readings.
Monastra now uses a technique known as multi-channel
neurofeedback. Instead of focusing on just one part of the brain,
the technique gives readings from many brain regions.
"As we become more aware of the different subtypes
of neurological problems, we use specific protocols to address those
problems," he says. "Chances are we'll start to get even
more robust results."
Multi-channel neurofeedback surveys the brain's surface
to locate an abnormality, but another type of therapy actually looks
into the core. The therapy — low-resolution electromagnetic
tomography — can show clinicians signals from regions deep
below the scalp.
"The idea is, if we can get more specific, we
can intervene faster and more effectively," says Leslie Sherlin,
who is getting his doctorate in psychology at Capella University
in Minnesota.
In tests with obsessive-compulsive patients, Sherlin
located increased neural activity in the cingulate gyrus, an area
toward the brain's core that's involved in regulating attention
and arousal.
Over-arousal in this area causes patients to ruminate
on germs or other obsessions, he says. Teaching patients to regulate
the brain waves from the gyrus could lead to improved treatment
of obsessive-compulsive disorder, according to an analysis of the
technique that Sherlin published in Neuroscience Letters in 2005.
Promising but not yet accepted
Neurofeedback has yet to achieve widespread acceptance.
"Many people out there feel threatened by it, because people
are putting it out there as alternative," says psychologist
Jeffrey Bone, who runs a private practice in Orange County and began
using neurofeedback a year ago.
"I see it as a complement to medicine or psychotherapy,
not a challenge or alternative." But neurofeedback researchers
expect acceptance of the therapy to grow.
For starters, the therapy is cost effective, they
say. In the case of asthma, for example, if a biofeedback session
costs about $150 — a typical rate in most clinics (neurofeedback
costs about the same) — then the patient has
acquired an unlimited therapeutic tool for the price of about four
months of steroid medication, says Paul Lehrer, professor of psychiatry
at Robert Wood Johnson Medical School in New Jersey.
Says UCLA's Sideroff: "There are a lot of obstacles.
But it's an effective tool, so I think it will keep growing."
Original Link at:
http://www.latimes.com/news/health/la-he-lab27nov27,1,5487698.story
(no longer valid)
This article is available
in PDF using Adobe Reader.
|